By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tesaro, Inc. (Waltham, Massachusetts) 

309 Waverley Oaks Road
Suite #101
Waltham  Massachusetts  02452  U.S.A.
Phone: 339-970-0900 Fax: n/a



Company News
Tesaro (TSRO) To Announce Second-Quarter 2016 Financial Results On August 4, 2016 7/22/2016 8:44:09 AM
ENGOT And Tesaro (TSRO) Partnership Generates Positive Data From ENGOT-OV16/NOVA Phase 3 Trial 7/11/2016 8:29:48 AM
Tesaro (TSRO) Announces Closing Of Public Offering Of Common Stock And Exercise Of Option By Underwriters 7/8/2016 9:45:15 AM
Tesaro (TSRO) Stock Soars as Acquisition Rumors Swirl After Excellent Phase III Results 7/1/2016 8:16:29 AM
Myriad Genetics (MYGN)’s myChoice HRD Test Successfully Identifies Patients That Meet Primary Endpoint In Tesaro (TSRO)’s Pivotal Phase 3 Ovarian Cancer Study With Niraparib 6/29/2016 6:58:24 AM
Tesaro (TSRO)'s Phase III NOVA Trial of Niraparib Hits Primary Endpoint; NDA and MAA Planned for Q4 2016 6/29/2016 6:27:06 AM
Tesaro (TSRO) Announces Rolapitant Data Presentations At The 2016 MASCC/ISOO Annual Meeting On Supportive Care In Cancer 6/24/2016 9:16:00 AM
Wuxi Biologics Congratulates Tesaro (TSRO) For Anti-TIM-3 Antibody IND Submission In The U.S. 5/10/2016 11:24:43 AM
Tesaro (TSRO) Announces First-Quarter 2016 Operating Results 5/6/2016 8:06:33 AM
Tesaro (TSRO) Announces Submission Of Investigational New Drug Application For Anti-TIM-3 Antibody TSR-022 To The FDA 4/25/2016 9:29:27 AM